This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Sep 2026 quarter, Rs crore: revenue 274.68 vs 270.23; profit 28.90 vs 21.19 year ago
EXCELINDUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated Sep 2026 quarter: revenue rose 1.6 percent to Rs 274.68 crore from Rs 270.23 crore a year earlier, while profit after tax rose 36.4 percent to Rs 28.90 crore from Rs 21.19 crore. Exceptional items were Rs 1.14 crore. For the consolidated half-year, profit after tax rose 6.2 percent to Rs 58.36 crore from Rs 54.95 crore a year ago, but operating cash flow was an outflow of Rs 63.43 crore. Board approved the unaudited results.
Profit growth and operating margin gains help, but an exceptional charge, flat sales and operating cash outflow of Rs 63.43 crore may pressure shares.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹274.7 Cr | ₹270.2 Cr | +1.6% |
| Operating profit | ₹25.34 Cr | ₹20.03 Cr | +26.5% |
| Profit after tax | ₹28.90 Cr | ₹21.19 Cr | +36.4% |
| EBITDA margin | 13.3% | 11.1% | +2.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.